Solventum Corp. (SOLV)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 8,253,000 | 8,274,000 | 8,246,000 | 8,208,500 | 8,236,000 | 8,146,000 | 8,101,000 | 8,115,500 | 8,130,000 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | — | — | — |
| Fixed asset turnover | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $8,253,000K ÷ $—K
= —
The fixed asset turnover ratio for Solventum Corp. is not provided for the periods between December 31, 2022, and December 31, 2024. This ratio is typically used to assess a company's efficiency in generating sales revenue from its investment in fixed assets. Without specific data points to compute this ratio, it is challenging to evaluate Solventum Corp.'s utilization of its fixed assets to generate sales during the mentioned period. It is essential to monitor this ratio over time to assess changes in the company's operational efficiency and capital utilization.
Peer comparison
Dec 31, 2024
Company name
Symbol
Fixed asset turnover
Solventum Corp.
SOLV
—
3M Company
MMM
3.33
Artivion Inc
AORT
9.56
Baxter International Inc
BAX
3.37
Becton Dickinson and Company
BDX
2.96
Boston Scientific Corp
BSX
4.89
DexCom Inc
DXCM
3.24
Embecta Corp
EMBC
4.30
Glaukos Corp
GKOS
3.82
Globus Medical
GMED
2.67
Haemonetics Corporation
HAE
8.34